Cholesterol emboli syndrome epidemiology and demographics

Cholesterol emboli syndrome Microchapters
Home
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Cholesterol emboli syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cholesterol emboli syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cholesterol emboli syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cholesterol emboli syndrome epidemiology and demographics
CDC on Cholesterol emboli syndrome epidemiology and demographics
Cholesterol emboli syndrome epidemiology and demographics in the news
Blogs on Cholesterol emboli syndrome epidemiology and demographics
Directions to Hospitals Treating Cholesterol emboli syndrome
Risk calculators and risk factors for Cholesterol emboli syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

• Cholesterol emboli syndrome is more common in male patients (~75%) with severe atherosclerotic disease, and often occurs days to weeks after an invasive procedure.

References

Template:WikiDoc Sources